Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MOv18 IgE by Epsilogen for Breast Cancer: Likelihood of Approval
MOv18 IgE is under clinical development by Epsilogen and currently in Phase I for Breast Cancer. According to GlobalData, Phase...